Messages from completed randomized trials in head and neck cancer

European Journal of Surgical Oncology

Volumn 23, Issue 6, 1997, Pages 469-476

  Leemans, Charles R ^a   Chiesa, Fausto ^b   Tradati, Nicoletta ^b   Snow, Gordon B ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Chemoprevention; Head and neck neoplasms; Randomized controlled trials; Squamous cell carcinoma

Indexed keywords

ANTI ACNE AGENT; BLEOMYCIN; CISPLATIN; FLUOROURACIL; FOLIC ACID ANTAGONIST; ISOTRETINOIN; METHOTREXATE; VINCRISTINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ELECTIVE SURGERY; HEAD AND NECK CANCER; HUMAN; MOUTH CARCINOMA; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031471649     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(97)92725-6     Document Type: Article

References (53)

1. Vandenbrouck C, Sancho-Garnier H, Chassagne D, et al. Elective versus therapeutic neck dissection in epidermoid carcinoma of the oral cavity. Cancer 1980; 46: 386-90.
2. Fakih AR, Rao RS, Patel RA. Prophylactic neck dissection in squamous cell carcinoma of the oral tongue: a prospective randomized study. Semin Surg Oncol 1989; 5: 327-30.
3. Fakih AR, Rao RS, Borges AM, et al. Elective versus therapeutic neck dissection in early carcinoma of the oral tongue. Am J Surg 1989; 158: 309-13.
4. Vandenbrouck C, Sancho H, Le Fur L, et al. Results of a randomized clinical trial of preoperative irradiation versus postoperative in treatment of tumours of the hypopharynx. Cancer 1977; 39: 1445-9.
5. Snow JB, Gelber RD, Kramer S, et al. Evaluation of randomized preoperative and postoperative radiation therapy for supraglottic carcinoma: preliminary report. Ann Otol Rhinol Laryngol 1978; 87: 686-91.
6. Snow JB, Gelber RD, Kramer S, et al. Randomized preoperative and postoperative radiation therapy for patients with carcinoma of the head and neck: preliminary report. Laryngoscope 1980; 90: 930-45.
7. Kramer S, Gelber R, Snow JB, et al. Combined therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg 1987; 10: 19-30.
8. Tupchong L, Scott CB, Blitzer PH, et al. Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03. Int J Radiat Oncol Biol Phys 1991; 20: 21-8.
9. Dische S. Radiotherapy - new fractionation schemes. Semin Oncol 1994; 21: 304-10.
10. Horiot JC, Le Fur R, N'Guyen T, et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radio-therapy. Radiother Oncol 1992; 25: 231-41.
11. Van den Bogaert W, van der Schueren E, Horiot JC, et al. The EORTC randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: long-term results and side effects. Radiother Oncol 1995; 35: 91-9.
12. Head and Neck Contracts Program. Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Cancer 1987; 60: 301-11.
13. Schuller DE, Metch B, Mattox D, et al. Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Group. Laryngoscope 1988; 98: 1205-11.
14. Laramore GE, Scott CB, Al-Sarraf M, et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on intergroup study 0034. Int J Radiat Oncol Biol Phys 1992; 23: 7-713.
15. Cooper JS, Scott CB, Laramore GE, et al. Sequential adjuvant chemotherapy for advanced head and neck cancers. In: Johnson JT, Didolkar MS (eds) Head and Neck Cancer. Vol. III. Amsterdam: Elsevier Science Publishers, 1993: 307-12.
16. The Department of Veteran Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. New Engl J Med 1991; 324: 1685-90.
17. Wolf GT, Hong WK, and the Department of Veteran Affairs Laryngeal Cancer Study Group. Induction chemotherapy as part of a new treatment strategy to preserve the larynx in advanced laryngeal cancer. In: Johnson JT, Didolkar MS (eds) Head and Neck Cancer, Vol. III. Amsterdam: Elsevier Science Publishers, 1993: 27-36.
18. Paccagnella A, Orlando A, Marchiori C, et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 1994; 16: 265-72.
19. Jacobs C, Makuch R. Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the Head and Neck Contracts Program. J Clin Oncol 1990; 8: 838-47.
20. Stell PM, Rawson NSB. Adjuvant chemotherapy in head and neck cancer. Br J Cancer 1990; 61: 779-87.
21. El-Sayed S, Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials. J Clin Oncol 1996; 14: 838-47.
22. Al-sarraf M, LeBlanc M, Giri PG, et al. Superiority of chemoradiotherapy (CT-RT) vs radiotherapy (RT) in patients (pts) with locally advanced nasopharyngeal cancer (NPC). Preliminary results of intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) randomized study. Proc Am Soc Clin Oncol 1996; 15: 313.
23. Levebvre JL, Chevalier D, Luboinski B, et al. For the EORTC Head and Neck Cancer Cooperative Group. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 1996; 88: 890-9.
24. Beauvillain C, Mahe M, Bourdin S, et al. Final results of a randomized trial comparing chemotherapy plus radiotherapy with chemotherapy plus surgery plus radiotherapy in locally advanced resectable hypopharyngeal carcinomas. Laryngoscope 1997; 107: 648-53.
25. Merlano M, Vitale V, Rosso R, et al. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 1992; 327: 1115-21.
26. Merlano M, Benasso M, Corvo R, et al. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 1996; 88: 583-9.
27. Glisson B, Hong WK. Primary chemotherapy of advanced head and neck cancer: where do we go from here? J Natl Cancer Inst 1996; 88: 567-8.
28. Clark JR, Dreyfuss AI. The role of cisplatin in treatment regimens for squamous cell carcinomas of the head and neck. Semin Oncol 1991; 18: 34-48.
29. Hong WK, Schaefer S, Issell B, et al. A prospective randomized trial of methotrexate versus cisplatin in the treatment for recurrent squamous cell carcinoma of the head and neck. Cancer 1983; 52: 206-10.
30. Grose WE, Lehane DE, Dixon DO, et al. Comparison of methotrexate and cisplatin for patients with advanced squamous cell carcinoma of the head and neck region: a Southwest Oncology Group Study. Cancer Treat Rep 1985; 69: 577-81.
31. Browman GP, Cronin L. Standard chemotherapy in squamous cell head and neck cancer: what we have learned from randomized trials? Semin Oncol 1994; 21: 311-9.
32. Jacobs C, Lyman G, Velez-Garcia E, et al. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 1992; 10: 257-63.
33. Forastiere AA, Metch B, Schuller DE, et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous cell carcinoma of the head and neck: a Southwest Oncology Group Study. J Clin Oncol 1992; 10: 1245-51.
34. Clavel M, Vermorken JB, Cappelaere P, et al. Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. Ann Oncol 1994; 5: 521-6.
35. Tradati N, Grigolato R, Calabrese L, et al. Oral leukoplakias: to treat or not to treat. Oral Oncol 1997; 33B: 149-54.
36. Stich HF, Rosin MP, Hornby AP. Remission of oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with beta-carotene and with beta-carotene plus vitamin A. Int J Cancer 1988; 42: 195-9.
37. Garewal HS, Pitcock J, Friedman S, et al. Beta-carotene in oral leukoplakia. Proc Am Soc Clin Oncol 1992; 11: 141-8.
38. Stich HF, Hornby AP, Mathew B. Response of oral leukoplakias to the administration of vitamin A. Cancer Lett 1988; 40: 93-101.
39. Hong WK, Endicott J, Itri LM, et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986; 315: 1501-5.
40. Lippman SM, Balsakis JG, Toth BB, et al. Comparison of low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis. N Engl J Med 1993; 328: 15-20.
41. Papadimitrakopoulou VA, Hong WK, Lee JS, et al. Low-dose isotretinoin versus carotene to prevent oral carcinogenesis: long-term follow-up. J Natl Cancer Inst 1997; 89: 257-8.
42. Benner SE, Winn RJ, Lippman SM, et al. Regression of oral leukoplakia with tocopherol: a community clinical program (CCOP) chemoprevention study. J Natl Cancer Inst 1993; 85: 44-7.
43. Zaridse D, Evstifeeva T, Boyle P. Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer. Ann Epidemiol 1993; 3: 225-34.
44. Chiesa F, Tradati N, Marazza M, et al. Prevention of local relapses and new localizations of oral leukoplakias with the synthetic retinoid Fenretinide (4-HPR). Preliminary results. Oral Oncol 1992; 28B: 97-102.
45. Chiesa F, Tradati N, Marazza M, et al. Fenretinide (4-HPR) in chemoprevention of oral leukoplakia. J Cell Biochem 1993; (Suppl. 17F): 255-9.
46. Hong WK, Lippman SM, Itri LM, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990; 323: 795-801.
47. Benner SE, Pajak TF, Lippman SM, et al. Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: Long-term follow-up. J Natl Cancer Inst 1994; 86: 140-1.
48. Bolla M, Lefur R, Ton Van J, et al. Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx. Results of a multicentric double-blind randomized study. Eur J Cancer 1994; 30: 767-72.
49. Blot WJ, Li JY, Taylor PR, et al. Nutrition intervention trials in Linxian, China supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993; 85: 1483-92.
50. The Alpha-tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029-35.
51. Albanes D, Olli PH, Taylor PR, et al. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene Cancer Prevention Study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996; 88: 1560-70.
52. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334: 1145-9.
53. Omenn OS, Goodman GE, Thorquist MD, et al. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular diseases. N Engl J Med 1996; 334: 1150-5.